Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
- PMID: 31118066
- PMCID: PMC6532174
- DOI: 10.1186/s13054-019-2469-7
Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
Conflict of interest statement
The authors declare that they have no competing interests.
Comment in
-
Endocan is a reliable biomarker during continuous renal replacement therapy.Crit Care. 2019 Sep 3;23(1):296. doi: 10.1186/s13054-019-2585-4. Crit Care. 2019. PMID: 31481101 Free PMC article. No abstract available.
Comment on
-
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.Crit Care. 2018 Oct 26;22(1):280. doi: 10.1186/s13054-018-2222-7. Crit Care. 2018. PMID: 30367649 Free PMC article. Review.
References
-
- Peters E, Antonelli M, Wittebole X, Nanchal R, François B, Sakr Y, et al. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit. Crit Care. 2018;22(1):188. doi: 10.1186/s13054-018-2112-z.. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical